healthliberal
Maryland’s New Hospital Payment System and Cancer Care
Maryland, USAThursday, March 5, 2026
In 2014, the state of Maryland shifted its hospital reimbursement strategy from a fee‑for‑service model to a Global Budget Revenue (GBR) system. Under GBR, each hospital receives a fixed annual payment instead of per‑service billing. The goal: curb spending while promoting higher quality care.
Why Cancer Care Matters
- Chemotherapy’s Cost and Complexity
Chemotherapy is expensive, often requiring frequent visits and multiple drug regimens. A flat payment structure could influence: - Scheduling of treatment sessions
- Drug selection (generic vs. brand‑name)
Resource allocation within hospitals
Research Gap
No comprehensive studies yet examine how GBR affects cancer patients, particularly those on chemotherapy.
Conflicting Perspectives
| Concern | Argument |
|---|---|
| Potential Service Reduction | A fixed budget may incentivize hospitals to cut high‑cost services for cancer patients. |
| Resource Efficiency | Hospitals might become more strategic, potentially improving care quality and patient outcomes. |
What’s Needed to Decide
- Data Comparison
- Pre‑GBR vs. post‑GBR hospital performance metrics.
- Key Metrics
- Treatment timelines (time to start, frequency of sessions).
- Medication choices (drug types, dosage adjustments).
- Patient satisfaction scores.
- Policy Implications
- Evidence‑based decisions on whether GBR truly benefits cancer care.
Bottom Line
The impact of Maryland’s Global Budget Revenue model on cancer patients remains uncertain. Rigorous, data‑driven research is essential to determine whether the fixed payment structure supports or hinders optimal chemotherapy care.
Actions
flag content
